PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-76.02%
Negative net income growth while TSM stands at 8.89%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
2.83%
D&A growth well above TSM's 5.63%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
100.00%
Some yoy growth while TSM is negative at -7.58%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-100.00%
Negative yoy SBC while TSM is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-448.87%
Both reduce yoy usage, with TSM at -419.87%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
100.00%
AR growth of 100.00% while TSM is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-5668.64%
Both reduce yoy inventory, with TSM at -192.16%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-100.00%
Negative yoy AP while TSM is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-617.84%
Both reduce yoy usage, with TSM at -507.27%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
682.30%
Well above TSM's 164.42%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-146.99%
Both yoy CFO lines are negative, with TSM at -23.18%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
10.60%
Lower CapEx growth vs. TSM's 66.06%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
86.34%
Purchases well above TSM's 50.15%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-38.13%
We reduce yoy sales while TSM is 178.68%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
110.26%
Investing outflow well above TSM's 75.14%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-69.66%
Negative yoy issuance while TSM is 135.58%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.